Innovative Medicines Initiative [IMI]

The processes of patient involvement in industry medicines research and development have evolved, but the evolution of frameworks, mechanisms, metrics and processes happens individually without much alignment and sharing.

Safety communication is put in place to communicate adverse reactions or any safety findings to regulators, healthcare providers and patients. Safety communications are provided by marketing authorisation holders and health authorities, and may include restrictions, contraindications, dose limitations, warnings, and recommendations.